The unsealed documents reveal that AstraZeneca “buried” unfavorable studies that showed Seroquel posed a serious risk for diabetes. Continue reading →
Bloomberg News
Seroquel Litigation Documents–Sexual Exploitation
A document filed in Federal District Court, Orlando Fla, by plaintiffs "in response to AstraZeneca’s motion to exclude evidence and argument about Dr. Macfadden’s personal relationships," sheds light on yet another facet of manipulation–sexual exploitation.
Continue reading →
Court Ruling: Injunction on Release of Zyprexa Documents
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetes Continue reading →
Zyprexa Documents Court Ruling
Despite Lilly's efforts to suppress the documents, they are available on internet websites.
Judge Jack Weinstein rejected Lilly's effort to seek a court injunction against internet posting
of the documents. Continue reading →
SEC Filings: Eli Lilly Admits Problems Getting Liability Insurance For Zyprexa
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller. Continue reading →
Cong. Hearings Loom: Pfizer, Halliburton
“No general counsel or CEO wants to have to explain to his board why the company's name is appearing on the front page of a news article in a scandal…"
Texas Attorney General Joins Whistleblower Lawsuit against J & J
Two ground breaking legal actions in Texas to rein in out of control psychotropic drug prescribing will have nationwide reverberations.
IRB Forum Not Inclined to Discuss the Most Serious Issue of All
Unssuccessful effort to engage debate within the community of the authorized clinical research gatekeepers charged with protecting the safety and welfare of the human subjects of research–i.e., members of institutional review boards (IRBs–REBs in Canada). Continue reading →
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
Continue reading →
FDA says it Screened Panelists for Conflicts of Interest
FDA says it Screened Panelists for Conflicts of Interest Tue, 1 Mar 2005 Bloomberg News reports that the Center for Science in the Public Interest had identified not 10, but 27 panelists on FDA’s advisory panel who had financial ties to drug . . . Continue reading →
Another deadly drug recalled – FDA asks Congress for Power to Dictate Warnings
Another deadly drug recalled – FDA asks Congress for Power to Dictate Warnings Tue, 1 Mar 2005 Public pressure has intensified as FDA’s failure to protect the public from unsafe – even lethal drugs. That failure included the failure to at least . . . Continue reading →
Lilly Shares Fall After BMJ Report About Prozac Documents – NYT
Lilly Shares Fall After BMJ Report About Prozac Documents – NYT Sat, 1 Jan 2005 The New York Times reports that Jeanne Lenzer’s investigative report in the current (Jan 1) British Medical Journal, citing Eli Lilly secret documents showing that company officials . . . Continue reading →